Featured Image for Olympic Ophthalmics, Inc. ISSAQUAH, Wash., March 30, 2022 (GLOBE NEWSWIRE) -- Olympic Ophthalmics announced today that the U.S. Food and Drug Administration (FDA) has granted its ...

Dublin, July 18, 2025 (GLOBE NEWSWIRE) -- The "Ophthalmics Collaboration and Licensing Deals 2019-2024" report has been added to ResearchAndMarkets.com's offering. Fully revised and updated, the ...

DUBLIN--(BUSINESS WIRE)--The "Ophthalmics Collaboration and Licensing Deals 2019-2024" report has been added to ResearchAndMarkets.com's offering. Fully revised and updated, the report provides ...

TEL AVIV, Israel--(BUSINESS WIRE)--Azura Ophthalmics Ltd. (Azura), a clinical-stage biotechnology company developing innovative therapies for meibomian gland dysfunction (MGD), today announced it has ...

MediPrint® Ophthalmics, a clinical-stage ophthalmic drug delivery company, is accelerating a new clinical program aimed at tackling one of the largest challenges in contact lens ...

Please provide your email address to receive an email when new articles are posted on . Shape Ophthalmics’ proprietary shape-memory polymer punctal plug for dry eye treatment has demonstrated a 93.6% ...

FLORHAM PARK, N.J. and TAMPA, Fla., July 27, 2023 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“Celularity”), a biotechnology company developing placental-derived allogeneic cell therapies and ...

CXL Ophthalmics is currently developing minimally invasive treatment options for patients with corneal disease. Dr. Talamo worked in clinical practice for 25 years, specializing in corneal disease, ...

Agreement Includes Global Rights for Risuteganib, An Investigational Treatment Expected to Help Reverse Vision Loss Due to Dry AMD, A Significant Unmet Medical Need LAVAL, QC and SAN JUAN CAPISTRANO, ...

Google and other tech companies have come up with glasses and contact lenses for the purposes of AR, but Omega Ophthalmics is taking a much more invasive approach by using surgically implanted lenses ...

Please provide your email address to receive an email when new articles are posted on . In early 2001 we saw the transition of Novartis Ophthalmics from CIBA Vision to become a separate business unit.